Status:

COMPLETED

Preoperative Inflammatory Status and Postoperative Acute Kidney Injury

Lead Sponsor:

Rao Sun

Conditions:

Postoperative Acute Kidney Injury

Eligibility:

All Genders

65-100 years

Brief Summary

Acute kidney injury (AKI) is a common complication during the early postoperative period after noncardiac surgery. Patients with AKI are at an increased risk of developing chronic kidney disease, prol...

Eligibility Criteria

Inclusion

  • aged ≥ 65 years.
  • general, gynaecological, neurosurgery, orthopaedic, or thoracic surgery.
  • surgery duration lasting longer than one hour.

Exclusion

  • patients with an American Society of Anesthesiologists (ASA) physical status V.
  • those with concurrent cardiac, vascular, transplant or urological surgeries.
  • those with end-stage renal disease (i.e. a glomerular filtration rate of 15 mL/min/1.73 m2 or receiving haemodialysis) or a history of kidney transplantation..
  • those did not have sufficient data required for calculation for inflammatory markers or AKI evaluation.

Key Trial Info

Start Date :

September 10 2023

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 5 2023

Estimated Enrollment :

8472 Patients enrolled

Trial Details

Trial ID

NCT06027476

Start Date

September 10 2023

End Date

October 5 2023

Last Update

November 22 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rao Sun

Wuhan, China